Dermata Therapeutics DRMA
NASDAQ DRMA
$0.68 -0.03 (-4.70%)
As of: Nov 11, 2026 · 2:43 PM EST

Dermata Therapeutics (DRMA) Return on Capital Employed [ROCE] (2021)

Updated

Dermata Therapeutics' Return on Capital Employed [ROCE] came in at -70.54% for Q4 2021, up 22.69 percentage points from the prior quarter.

Analysis

Dermata Therapeutics (DRMA) Return on Capital Employed [ROCE] (2021) Analysis & Trends

For FY2021, Dermata Therapeutics' Return on Capital Employed [ROCE] was -170.88%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Procter & Gamble 390.78 Bn 342.58 Bn 11.60 Bn 23.37%
2 Colgate Palmolive 77.96 Bn 72.79 Bn 3.23 Bn 31.20%
3 Estee Lauder Companies 41.21 Bn 28.31 Bn 2.81 Bn 7.49%
4 Kenvue 37.02 Bn 32.73 Bn 2.31 Bn 13.21%
5 Kimberly Clark 36.84 Bn 32.92 Bn 1.44 Bn 21.00%
6 Church & Dwight 26.38 Bn 24.77 Bn 749.40 Mn 15.26%
7 Clorox 12.88 Bn 11.29 Bn 770.00 Mn 37.50%
8 e.l.f. Beauty 7.00 Bn 5.82 Bn 370.22 Mn 8.06%
9 Reynolds Consumer Products 5.26 Bn 4.95 Bn 236.00 Mn 11.51%
10 Dermata Therapeutics 3.50 Mn -280.22 Mn 40,129.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -70.54%
Sep 30, 2021 -93.23%
API Access

Dermata Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DRMA&period=max&api_key=YOUR_API_KEY